Services

Listings
  • Anti-EFNA4 (clone huE22)-AcBut-CM ADC

    Anti-EFNA4 (clone huE22)-AcBut-CM ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-EFNA4 monoclonal antibody (clone huE22)) conjugated via an AcBut linker to CM. The CM is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. http...

  • Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-24P4C12 monoclonal antibody (clone Ha5-l(5)2.1)) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytos...

  • Anti-158P1D7 (clone Hal5-10acl2)-VC-MMAE ADC

    Anti-158P1D7 (clone Hal5-10acl2)-VC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-158P1D7 monoclonal antibody (clone Hal5-10acl2) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-EGFR-Mc-MMAF ADC

    Anti-EGFR-Mc-MMAF ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a Mc linker to MMAF. The MMAF is targeted to EGFR-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-EGFR-Mc-VC-PABC-MMAE ADC

    Anti-EGFR-Mc-VC-PABC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to EGFR-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-EGFR-Mc-VC-PABC-MMAE ADC

    Anti-EGFR-Mc-VC-PABC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to EGFR-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-161P2F10B (clone H16-7.8)-Mc-MMAF ADC

    Anti-161P2F10B (clone H16-7.8)-Mc-MMAF ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti- 161P2F10B monoclonal antibody (clone H16-7.8 ) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-IL13RA2 (clone hu08)-Mc- ADC

    Anti-IL13RA2 (clone hu08)-Mc- ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug. https://www.creative-biolabs.com/adc/target-il13ra2-57.htm

  • Anti-IL13RA2 (clone hu08)-Mc- ADC

    Anti-IL13RA2 (clone hu08)-Mc- ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug. https://www.creative-biolabs.com/adc/target-il13ra2-57.htm

  • Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via an MalPeg linker to a drug. https://www.creative-biolabs.com/adc/target-il13ra2-57.htm

  • Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Anti-TPBG (clone A1)-AcBut-calicheamicin ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via an AcBut linker to calicheamicin. The calicheamicin is targeted to TPBG-positive cancers by immunerecognition and delivered into cancer cells via receptor med...

  • Anti-TPBG (clone A3)-VC-MMAE ADC

    Anti-TPBG (clone A3)-VC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A3) conjugated via a VC linker to MMAE. The MMAE is targeted to TPBG-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wit...